Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qt Imaging Holdings (QTI) Change in Cash (2021 - 2026)

Qt Imaging Holdings (QTI) reported Change in Cash of -$3.5 million for Q1 2026, down 293.39% year-over-year from $1.8 million in Q1 2025, and down 140.24% on a QoQ basis from $8.7 million in Q4 2025.

Qt Imaging Holdings (QTI) has 6 years of Change in Cash data on file, last reported at -$3.5 million in Q1 2026.

  • Quarterly Change in Cash fell 293.39% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 249.74% YoY) and the FY2025 annual result came in at $9.3 million, up 820.56% from the prior year.
  • Change in Cash slipped to -$3.5 million in Q1 2026 per QTI's latest filing, from $8.7 million in the prior quarter.
  • Across five years, Change in Cash topped out at $8.7 million in Q4 2025 and bottomed at -$3.5 million in Q1 2026.
  • The 5-year median for Change in Cash is -$201545.0 (2023), against an average of $360662.2.
  • Peak annual rise in Change in Cash reached 7183.38% in 2024, while the deepest fall reached 1406.85% in 2024.
  • Tracing QTI's Change in Cash over 5 years: stood at -$407461.0 in 2022, then surged by 131.95% to $130196.0 in 2023, then tumbled by 386.09% to -$372483.0 in 2024, then jumped by 2442.85% to $8.7 million in 2025, then slumped by 140.24% to -$3.5 million in 2026.
  • Per Business Quant, the three latest QTI Change in Cash figures stand at -$3.5 million (Q1 2026), $8.7 million (Q4 2025), and -$306780.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Qt Imaging Holdings 67.06 Mn 67.06 Mn 2.67 Mn -3.51 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.51 Mn
Dec 31, 2025 8.73 Mn
Sep 30, 2025 -306,780.00
Jun 30, 2025 -965,924.00
Mar 31, 2025 1.82 Mn
Dec 31, 2024 -372,483.00
Sep 30, 2024 -3.04 Mn
Jun 30, 2024 -1.04 Mn
Mar 31, 2024 5.46 Mn
Dec 31, 2023 130,196.00
Sep 30, 2023 -201,545.00
Jun 30, 2023 -142,022.00
Mar 31, 2023 -77,019.00
Dec 31, 2022 -407,461.00
Sep 30, 2022 430,499.00
Jun 30, 2022 -136,940.00
Mar 31, 2022 -229,451.00
Dec 31, 2021 -1.63 Mn
Sep 30, 2021 2.01 Mn
Mar 31, 2021 45,212.00